Suchergebnisse - "Nasir, Aejaz"

PubPharm (72)

1

p21 Protein Outperforms Clinico-pathological Criteria in Predicting Liver Metastases in Pancreatic Endocrine Tumors

enthalten in: Cancer genomics & proteomics | 2023

von Nasir, A. | Ahmed, M. | Saller, J. | +4

2

An Analysis of the Impact of COVID-19 Pandemic-related Lockdown Measures on a Large Gastrointestinal Pathology Service in the United States

enthalten in: Cancer diagnosis & prognosis | 2022

von Nasir, A. | Hough, B. | Baffa, C. | +2

3

Expression of DNA Mismatch Repair Proteins, PD1 and PDL1 in Barrett's Neoplasia

enthalten in: Cancer genomics & proteomics | 2022

von Saller, J. | Mora, L. | Nasir, A. | +3

4

Clinicopathologic analysis of primary gastroenteropancreatic poorly differentiated neuroendocrine carcinoma; A ten year retrospective study of 68 cases at Moffit Cancer Center

enthalten in: Pakistan journal of medical sciences | 2020

von Bukhari, M. | Coppola, D. | Nasir, A.

5

Cross-Platform Comparison of Computer-assisted Image Analysis Quantification of In Situ mRNA Hybridization in Investigative Pathology

enthalten in: Applied immunohistochemistry & molecular morphology : AIMM | 2019

von Holzer, T. | Hanson, J. | Wray, E. | +5

6

Efficacy and safety of ramucirumab-containing chemotherapy in patients with pretreated metastatic gastric neuroendocrine carcinoma

enthalten in: ESMO open | 2018

von Mishima, S. | Kawazoe, A. | Matsumoto, H. | +11

7

Phase 1 study of narnatumab, an anti-RON receptor monoclonal antibody, in patients with advanced solid tumors

enthalten in: Investigational new drugs | 2017

von LoRusso, P. | Gounder, M. | Jalal, S. | +9

8

Differential expression of VEGFR2 protein in HER2 positive primary human breast cancer: potential relevance to anti-angiogenic therapies

enthalten in: Cancer cell international | 2017

von Nasir, A. | Holzer, T. | Chen, M. | +2

9

Differential expression of VEGFR2 protein in HER2 positive primary human breast cancer: potential relevance to anti-angiogenic therapies

enthalten in: Cancer cell international | 2017

von Nasir, A. | Holzer, T. | Chen, M. | +2

10

Phase 1 study of narnatumab, an anti-RON receptor monoclonal antibody, in patients with advanced solid tumors

enthalten in: Investigational new drugs | 2017

von LoRusso, P. | Gounder, M. | Jalal, S. | +9

1
2
3
4
5
6
7
8
Nächster »
[8]